Andy
Retired committee member
Long COVID: tackling a multifaceted condition requires a multidisciplinary approach
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00043-8/fulltextIn their Comment, Dana Yelin and colleagues highlight the persistent, heterogeneous, and recurring symptoms of long COVID. A Lancet Editorial asks for better research and care to avoid years of struggle for individuals with long COVID. We write following an international, multi-stakeholder forum, in which peoples' voices were central, to expand the call to action and to identify how we can prevent long COVID from becoming the long-lasting legacy of COVID-19.
On Dec 9–10, 2020, the International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC), the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R) research funders group, and Long COVID Support, a global patient group, held the Long COVID Forum (appendix pp 1–2). We brought together people living with long COVID, interdisciplinary researchers, funders, public health experts, and policy makers, including WHO, in a global public forum to identify research gaps to inform urgent long COVID research and support priorities.